Sotera Health (SHC) reported Q2 adjusted earnings Thursday of $0.26 per diluted share, compared with $0.20 a year earlier.

Analysts surveyed by FactSet expected $0.24.

Revenue for the quarter ended June 30 was $321.4 million, compared with $294.3 million a year earlier.

Analysts surveyed by FactSet expected $309.7 million.

The company raised the lower end of its 2026 adjusted EPS guidance to a range of $0.95 to $1.01, from its previous outlook of $0.93 to $1.01.

The company also raised the lower end of its 2026 revenue outlook to a range of $1.24 billion to $1.25 billion, from previous guidance of $1.23 billion to $1.25 billion.

Analysts surveyed by FactSet expect 2026 adjusted EPS and revenue of $0.97 and $1.24 billion, respectively.

Shares of Sotera Health were up 3.1%.

Price: 18.51, Change: +0.52, Percent Change: +2.92